Gee they keep trying........Funding Gap!
The company raised 53mil in 2022 and has invested to increase the BTM output capacity to 500mil annually which is almost complete (from memory Early 2026).
They have circa 20mil on hand and are CF+
Please explain the funding gap you speak of as I just see a cash register overflowing with profits to reinvest!
Ann: BTM delivers positive First in Man results in Cell Therapies, page-46
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.035(2.87%) |
Mkt cap ! $818.6M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.15 | $1.635M | 1.394M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18287 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 42827 | 3 |
View Market Depth
| Last trade - 16.15pm 23/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |